IRadimed Corporation (IRMD)
IRadimed Statistics
Share Statistics
IRadimed has 12.67M shares outstanding. The number of shares has increased by 0.08% in one year.
| Shares Outstanding | 12.67M |
| Shares Change (YoY) | 0.08% |
| Shares Change (QoQ) | 0.03% |
| Owned by Institutions (%) | 53.17% |
| Shares Floating | 8M |
| Failed to Deliver (FTD) Shares | 82 |
| FTD / Avg. Volume | 0.19% |
Short Selling Information
The latest short interest is 148.74K, so 1.17% of the outstanding shares have been sold short.
| Short Interest | 148.74K |
| Short % of Shares Out | 1.17% |
| Short % of Float | 1.86% |
| Short Ratio (days to cover) | 3.51 |
Valuation Ratios
The PE ratio is 36.23 and the forward PE ratio is 34.69. IRadimed's PEG ratio is 3.08.
| PE Ratio | 36.23 |
| Forward PE | 34.69 |
| PS Ratio | 9.51 |
| Forward PS | 7.2 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 3.08 |
Enterprise Valuation
IRadimed Corporation has an Enterprise Value (EV) of 550.54M.
| EV / Earnings | 28.62 |
| EV / Sales | 7.52 |
| EV / EBITDA | 25.06 |
| EV / EBIT | 25.06 |
| EV / FCF | 100.87 |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is 23.69%.
| Return on Equity (ROE) | 0% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | 23.69% |
| Revenue Per Employee | $494,879.2 |
| Profits Per Employee | $129,959.64 |
| Employee Count | 148 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 5.04M |
| Effective Tax Rate | 0.21 |
Stock Price Statistics
The stock price has increased by 26.69% in the last 52 weeks. The beta is 0.83, so IRadimed's price volatility has been higher than the market average.
| Beta | 0.83 |
| 52-Week Price Change | 26.69% |
| 50-Day Moving Average | 57.23 |
| 200-Day Moving Average | 50.07 |
| Relative Strength Index (RSI) | 35.61 |
| Average Volume (20 Days) | 43.59K |
Income Statement
In the last 12 months, IRadimed had revenue of 73.24M and earned 19.23M in profits. Earnings per share was 1.52.
| Revenue | 73.24M |
| Gross Profit | 56.35M |
| Operating Income | 21.96M |
| Net Income | 19.23M |
| EBITDA | 21.96M |
| EBIT | 21.96M |
| Earnings Per Share (EPS) | 1.52 |
Balance Sheet
The company has 49.76M in cash and 2.04M in debt, giving a net cash position of 47.72M.
| Cash & Cash Equivalents | 49.76M |
| Total Debt | 2.04M |
| Net Cash | 47.72M |
| Retained Earnings | 43.26M |
| Total Assets | 94.25M |
| Working Capital | 66.22M |
Cash Flow
In the last 12 months, operating cash flow was 13.47M and capital expenditures -8.01M, giving a free cash flow of 5.46M.
| Operating Cash Flow | 13.47M |
| Capital Expenditures | -8.01M |
| Free Cash Flow | 5.46M |
| FCF Per Share | null |
Margins
Gross margin is 76.94%, with operating and profit margins of 29.99% and 26.26%.
| Gross Margin | 76.94% |
| Operating Margin | 29.99% |
| Pretax Margin | 33.14% |
| Profit Margin | 26.26% |
| EBITDA Margin | 29.99% |
| EBIT Margin | 29.99% |
| FCF Margin | 7.45% |
Dividends & Yields
IRMD pays an annual dividend of $0.62, which amounts to a dividend yield of 0.85%.
| Dividend Per Share | $0.62 |
| Dividend Yield | 0.85% |
| Dividend Growth (YoY) | 13.33% |
| Payout Ratio | 41.33% |
| Earnings Yield | 2.86% |
| FCF Yield | 0.81% |
Analyst Forecast
The average price target for IRMD is $72, which is 35.3% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $72 |
| Price Target Difference | 35.3% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 42.16 |
| Piotroski F-Score | 5 |